GeneDx
(NASDAQ) WGS
GeneDx Financials at a Glance
Market Cap
$1.88B
Revenue (TTM)
$427.54M
Net Income (TTM)
$21.02M
EPS (TTM)
$-0.74
P/E Ratio
-86.55
Dividend
$0.00
Beta (Volatility)
1.88 (High)
Dividend
$0.00
Beta (Volatility)
1.88 (High)
Price
$65.50
Volume
24,927
Open
$65.74
Price
$65.50
Volume
24,927
Open
$65.74
Previous Close
$64.22
Daily Range
$64.91 - $66.59
52-Week Range
$55.17 - $170.87
Dividend
$0.00
Beta (Volatility)
1.88 (High)
Price
$65.50
Volume
24,927
Open
$65.74
Previous Close
$64.22
Daily Range
$64.91 - $66.59
52-Week Range
$55.17 - $170.87
WGS News
WGS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout GeneDx
Industry
Healthcare Providers and Services
Sector
Health CareEmployees
1,300
CEO
Katherine A. Stueland
Website
www.genedx.comHeadquarters
Stamford, CT 06902, US
WGS Financials
Key Financial Metrics (TTM)
Gross Margin
68%
Operating Margin
-3%
Net Income Margin
-5%
Return on Equity
-8%
Return on Capital
-3%
Return on Assets
-4%
Earnings Yield
-1.16%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.88B
Shares Outstanding
29.29M
Volume
24.93K
Short Interest
0.00%
Avg. Volume
773.92K
Financials (TTM)
Gross Profit
$298.17M
Operating Income
$11.80M
EBITDA
$6.63M
Operating Cash Flow
$33.28M
Capital Expenditure
$19.02M
Free Cash Flow
$14.26M
Cash & ST Invst.
$171.28M
Total Debt
$151.95M
GeneDx Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$120.99M
+26.5%
Gross Profit
$78.92M
+19.2%
Gross Margin
65.23%
N/A
Market Cap
$1.88B
N/A
Market Cap/Employee
$1.88M
N/A
Employees
1,000
N/A
Net Income
$17.67M
-424.9%
EBITDA
$10.83M
-175.4%
Quarterly Fundamentals
Net Cash
$19.34M
-22.7%
Accounts Receivable
$74.37M
+97.6%
Inventory
$13.95M
+31.0%
Long Term Debt
$143.00M
+26.7%
Short Term Debt
$8.95M
+168.2%
Return on Assets
-3.69%
N/A
Return on Invested Capital
-2.72%
N/A
Free Cash Flow
$7.44M
-19.3%
Operating Cash Flow
$3.09M
+2.9%